Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-006046
Filing Date
2015-08-13
Accepted
2015-08-13 16:05:59
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0615_immucellcorp.htm 10-Q 762885
2 CERTIFICATION f10q0615ex31_immucellcorp.htm EX-31 7451
3 CERTIFICATION f10q0615ex32_immucellcorp.htm EX-32 4514
10 GRAPHIC image_002.jpg GRAPHIC 26105
  Complete submission text file 0001213900-15-006046.txt   3965012

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20150630.xml EX-101.INS 748829
5 XBRL SCHEMA FILE iccc-20150630.xsd EX-101.SCH 38636
6 XBRL CALCULATION FILE iccc-20150630_cal.xml EX-101.CAL 64586
7 XBRL DEFINITION FILE iccc-20150630_def.xml EX-101.DEF 75812
8 XBRL LABEL FILE iccc-20150630_lab.xml EX-101.LAB 334055
9 XBRL PRESENTATION FILE iccc-20150630_pre.xml EX-101.PRE 222957
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 151050715
SIC: 2835 In Vitro & In Vivo Diagnostic Substances